cysteine and gw9662
cysteine has been researched along with gw9662 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Blanchard, SG; Bledsoe, RK; Cobb, JE; Collins, JL; Consler, TG; Davis, RG; Hull-Ryde, EA; Leesnitzer, LM; Lenhard, JM; Parks, DJ; Patel, L; Plunket, KD; Shenk, JL; Stimmel, JB; Therapontos, C; Willson, TM | 1 |
| Akita, T; Irie, K; Kakizuka, A; Kambe, T; Maejima, K; Masuda, S; Miyamae, Y; Nagao, M; Ohtera, A; Yoshida, K | 1 |
| Atito, ASA; Isoda, H; Kawamura, Y; Kobuchi, H; Miyamae, Y; Nagao, M; Utsugi, Y | 1 |
Other Studies
3 other study(ies) available for cysteine and gw9662
| Article | Year |
|---|---|
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.
Topics: Adipocytes; Anilides; Binding Sites; Cell Differentiation; CREB-Binding Protein; Cysteine; Dimerization; Dose-Response Relationship, Drug; Escherichia coli; Humans; Ligands; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Repressor Proteins; Retinoid X Receptors; Trans-Activators; Transcription Factors | 2002 |
Identification of a New Type of Covalent PPARγ Agonist using a Ligand-Linking Strategy.
Topics: Anilides; Binding Sites; Binding, Competitive; Cysteine; Drug Delivery Systems; Drug Discovery; Hep G2 Cells; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; PPAR gamma | 2015 |
Importance of the Proximity and Orientation of Ligand-Linkage to the Design of Cinnamate-GW9662 Hybrid Compounds as Covalent PPARγ Agonists.
Topics: Anilides; Cinnamates; Cysteine; Hep G2 Cells; Humans; Ligands; Molecular Docking Simulation; PPAR gamma; Reproducibility of Results; Transcriptional Activation | 2019 |